Aytu BioPharma, Inc. (AYTU)

USD 1.31

(-1.88%)

Long Term Debt Summary of Aytu BioPharma, Inc.

  • Aytu BioPharma, Inc.'s latest annual long term debt in 2024 was 10.87 Million USD , down -26.07% from previous year.
  • Aytu BioPharma, Inc.'s latest quarterly long term debt in 2024 Q4 was 10.87 Million USD , down 0.0% from previous quarter.
  • Aytu BioPharma, Inc. reported annual long term debt of 14.71 Million USD in 2023, up 3.04% from previous year.
  • Aytu BioPharma, Inc. reported annual long term debt of 14.27 Million USD in 2022, up 409.24% from previous year.
  • Aytu BioPharma, Inc. reported quarterly long term debt of 5 Million USD for 2024 Q3, down -100.0% from previous quarter.
  • Aytu BioPharma, Inc. reported quarterly long term debt of 14.97 Million USD for 2024 Q2, up 0.92% from previous quarter.

Annual Long Term Debt Chart of Aytu BioPharma, Inc. (2024 - 2007)

Historical Annual Long Term Debt of Aytu BioPharma, Inc. (2024 - 2007)

Year Long Term Debt Long Term Debt Growth
2024 10.87 Million USD -26.07%
2023 14.71 Million USD 3.04%
2022 14.27 Million USD 409.24%
2021 2.8 Million USD 286.56%
2020 725.37 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 100.0%
2015 -425.89 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%

Peer Long Term Debt Comparison of Aytu BioPharma, Inc.

Name Long Term Debt Long Term Debt Difference
Esperion Therapeutics, Inc. 501.54 Million USD 97.831%
Theratechnologies Inc. 51.26 Million USD 78.781%
Safety Shot Inc 304.9 Thousand USD -3467.317%
Cosmos Health Inc. 3.03 Million USD -258.345%
Cronos Group Inc. 1.55 Million USD -597.691%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 97.817%
Kala Pharmaceuticals, Inc. 34.19 Million USD 68.187%
Organogenesis Holdings Inc. 60.74 Million USD 82.094%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD -6.034%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -12402.299%
Dynavax Technologies Corporation 252.41 Million USD 95.691%
Radius Health, Inc. 339.66 Million USD 96.798%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -9186.342%
Alvotech 1.02 Billion USD 98.942%
Sunshine Biopharma, Inc. 539.03 Thousand USD -1917.865%
Alpha Teknova, Inc. 13.25 Million USD 17.916%
Intra-Cellular Therapies, Inc. 13.32 Million USD 18.378%
SCYNEXIS, Inc. 12.15 Million USD 10.544%
Harrow Health, Inc. 183.17 Million USD 94.062%
Biofrontera Inc. 804 Thousand USD -1252.861%
DURECT Corporation 2.7 Million USD -302.554%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 67.234%
ANI Pharmaceuticals, Inc. 309.66 Million USD 96.488%
OptiNose, Inc. 611 Thousand USD -1680.196%
RedHill Biopharma Ltd. 455 Thousand USD -2290.549%
Aquestive Therapeutics, Inc. 91.07 Million USD 88.057%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 14.918%
SIGA Technologies, Inc. 335.99 Thousand USD -3137.289%
Lifecore Biomedical, Inc. 120.51 Million USD 90.974%
Shineco, Inc. 10.01 Million USD -8.582%
Phibro Animal Health Corporation 458.28 Million USD 97.627%
Procaps Group S.A. 28.41 Million USD 61.714%
TherapeuticsMD, Inc. 6.53 Million USD -66.519%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 16.18 Billion USD 99.933%
Sunshine Biopharma, Inc. 539.03 Thousand USD -1917.865%
Rockwell Medical, Inc. 8.29 Million USD -31.159%
Incannex Healthcare Limited 210 Thousand USD -5079.524%
Tilray Brands, Inc. 287.93 Million USD 96.222%
Collegium Pharmaceutical, Inc. 489.96 Million USD 97.78%
PetIQ, Inc. 437.82 Million USD 97.516%
Silver Spike Investment Corp. - USD -Infinity%
Neurocrine Biosciences, Inc. 258.3 Million USD 95.789%
Journey Medical Corporation 14.62 Million USD 25.612%
Alimera Sciences, Inc. 64.48 Million USD 83.134%
Petros Pharmaceuticals, Inc. 6.85 Million USD -58.618%
Assertio Holdings, Inc. 38.51 Million USD 71.758%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -7951.729%
Embecta Corp. 1.62 Billion USD 99.331%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -48276.623%
Procaps Group, S.A. 28.41 Million USD 61.714%
PainReform Ltd. 30 Thousand USD -36156.667%
Avadel Pharmaceuticals plc 32.75 Million USD 66.798%
Hempacco Co., Inc. 5.93 Million USD -83.392%
Talphera, Inc. - USD -Infinity%
Pacira BioSciences, Inc. 513.79 Million USD 97.883%
Alvotech 1.02 Billion USD 98.942%
Lantheus Holdings, Inc. 616.12 Million USD 98.235%
Kamada Ltd. 7.43 Million USD -46.236%
Indivior PLC 235.66 Million USD 95.385%
Currenc Group, Inc. 2.5 Million USD -333.87%
Evoke Pharma, Inc. 5 Million USD -117.54%
Flora Growth Corp. 942 Thousand USD -1054.671%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -48276.623%
Evolus, Inc. 120.35 Million USD 90.963%
HUTCHMED (China) Limited 48.18 Million USD 77.428%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 98.154%
Akanda Corp. 2.49 Million USD -335.576%